" What we know already is remarkable, compared to 10 years before, in neuroscience, clinical neuroscience and Alzheimer’s disease. There have been a lot of changes in the way we have approached Alzheimer’s disease in the last 10 years. I think with AI, modern medicine and hopefully, the confluence of the two, we have a long way to go. Technologies like brain imaging or genotyping with regular genetics and understanding lifestyle risk factors like depression, diet or obesity and how those things come together is where AI will play a significant role in the future and it’s a very exciting thing to think about. "